268 related articles for article (PubMed ID: 2972670)
1. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
Watanakunakorn C
J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
[TBL] [Abstract][Full Text] [Related]
2. In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.
Watanakunakorn C
J Antimicrob Chemother; 1990 Jan; 25(1):69-72. PubMed ID: 2138602
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
4. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
Goldstein FW; Coutrot A; Sieffer A; Acar JF
Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
[TBL] [Abstract][Full Text] [Related]
5. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
[TBL] [Abstract][Full Text] [Related]
6. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
[TBL] [Abstract][Full Text] [Related]
7. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
8. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
Del Bene VE; John JF; Twitty JA; Lewis JW
J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
[No Abstract] [Full Text] [Related]
9. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
11. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
12. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
13. In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.
Moore EP; Speller DC
J Antimicrob Chemother; 1988 Apr; 21(4):417-24. PubMed ID: 2967810
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of glycopeptide antibiotics against coagulase-negative staphylococci embedded in fibrin clots.
Cunningham R; Cheesbrough J
J Antimicrob Chemother; 1992 Sep; 30(3):321-6. PubMed ID: 1452497
[TBL] [Abstract][Full Text] [Related]
15. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.
Sieradzki K; Villari P; Tomasz A
Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268
[TBL] [Abstract][Full Text] [Related]
16. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
17. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.
Ahlstrand E; Svensson K; Persson L; Tidefelt U; Söderquist B
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1349-54. PubMed ID: 21744039
[TBL] [Abstract][Full Text] [Related]
18. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
Kayaokay Y; Hasçelik G; Gür D; Akalin E
Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
[TBL] [Abstract][Full Text] [Related]
19. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294
[TBL] [Abstract][Full Text] [Related]
20. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
Aubert G; Passot S; Lucht F; Dorche G
J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
